MTOR and breast carcinoma: Therefore, to further investigate how FolTAC-mediated HER2 degradation affects downstream signaling, we focused on the PI3K/AKT/mTOR pathway as HER2 is known to activate key regulatory nodes crucial for breast cancer cell survival and proliferation34,60,61.